Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Infinity Pharmaceuticals Inc (NASDAQ:INFI)

1.68
Delayed Data
As of Jul 29
 +0.06 / +3.70%
Today’s Change
1.24
Today|||52-Week Range
10.85
-78.60%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$83.1M

Company Description

Infinity Pharmaceuticals, Inc. is an innovative drug discovery and development company, which engages in discovering, developing and delivering medicines for difficult-to-treat diseases, developing novel small molecule drugs that target emerging disease pathways. Its programs focus on the inhibition of phosphoinositide-3-kinase, heat shock protein and fatty acid amide hydrolase. Infinity Pharmaceuticals was founded by Holtzman Steven H. on March 22, 1995 and is headquartered in Cambridge, MA.

Contact Information

Infinity Pharmaceuticals, Inc.
784 Memorial Drive
Cambridge Massachusetts 02139
P:(617) 453-1000
Investor Relations:
(617) 453-1336

Employees

Shareholders

Other institutional55.39%
Mutual fund holders46.96%
Individual stakeholders20.07%

Top Executives

Adelene Q. PerkinsChairman, President & Chief Executive Officer
Christopher M. LindblomTreasurer & Vice President-Finance
Julian AdamsPresident-Research & Development
Sujay KangoChief Commercial Officer & Executive VP
Winston K. C. LamExecutive Vice President & General Counsel